» Articles » PMID: 38375162

Examining the Roles of Travel Distance, Medical Mistrust, and Cancer Fatalism in the Uptake of Clinical Cancer Prevention Among Women in Rural and Urban US Communities: A Secondary Data Analysis

Overview
Journal Prev Med Rep
Date 2024 Feb 20
PMID 38375162
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Rural adults are less likely to receive cancer screening than urban adults, likely due to systematic differences in community- and individual-level factors. The purpose of this study was to analyze the relative contributions of rurality, travel time, medical mistrust, and cancer fatalism in explaining uptake of clinical cancer prevention services.

Methods: We conducted a secondary data analysis of 2019-2020 survey data from women, ages 45-65, in rural and urban counties in central Pennsylvania, examining rurality, travel time to a primary care provider, medical mistrust, and cancer fatalism, as well as uptake of guideline-recommended colorectal cancer screening, cervical cancer screening, and preventive check-up. Final models used multivariable logistic regression to assess the relationships among study variables, controlling for participant demographics.

Results: Among 474 participants, 48.9 % resided in rural counties. Most participants had received clinical cancer prevention services (colorectal cancer screening: 55.4 %; cervical cancer screening: 82.8 %; preventive check-up in the last year: 75.4 %). Uptake of services was less common among participants with higher medical mistrust (colorectal cancer screening: adjusted odds ratio [aOR] = 0.87, 95 % confidence interval [CI] = 0.76-1.00; cervical cancer screening: aOR = 0.79, 95 % CI = 0.63-1.00; last-year check-up: aOR = 0.74, 95 % CI = 0.63-0.88).

Conclusions: Patient attitudes, particularly medical mistrust, may contribute to rural/urban disparities in clinical cancer prevention among women. Community- and individual-level interventions are needed to improve cancer outcomes in rural areas.

Citing Articles

Prevalence and Predictors of Medical Mistrust Among Socioeconomically and Racially Diverse Cancer Patients in Philadelphia.

Hall M, Park C, Ruth K, Kelly P, Singley K, Luck C Cancers (Basel). 2025; 17(4).

PMID: 40002244 PMC: 11853404. DOI: 10.3390/cancers17040649.


What are the barriers and facilitators to help-seeking behaviour for symptoms in patients with ovarian cancer in China? A qualitative study.

Yin H, Zha Y, Zhou Y, Tao H, Zhu D BMJ Open. 2024; 14(11):e087602.

PMID: 39532367 PMC: 11574429. DOI: 10.1136/bmjopen-2024-087602.

References
1.
Segel J, Lengerich E . Rural-urban differences in the association between individual, facility, and clinical characteristics and travel time for cancer treatment. BMC Public Health. 2020; 20(1):196. PMC: 7006189. DOI: 10.1186/s12889-020-8282-z. View

2.
Espinosa de Los Monteros K, Gallo L . The relevance of fatalism in the study of Latinas' cancer screening behavior: a systematic review of the literature. Int J Behav Med. 2010; 18(4):310-8. PMC: 3212691. DOI: 10.1007/s12529-010-9119-4. View

3.
Syed S, Gerber B, Sharp L . Traveling towards disease: transportation barriers to health care access. J Community Health. 2013; 38(5):976-93. PMC: 4265215. DOI: 10.1007/s10900-013-9681-1. View

4.
LaVeist T, Isaac L, Williams K . Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009; 44(6):2093-105. PMC: 2796316. DOI: 10.1111/j.1475-6773.2009.01017.x. View

5.
Powe B, Finnie R . Cancer fatalism: the state of the science. Cancer Nurs. 2004; 26(6):454-65. DOI: 10.1097/00002820-200312000-00005. View